O'Shaughnessy Asset Management’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

O'Shaughnessy Asset Management’s Portfolio MRTX Stock Details MRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-68	Closed	-$12K	–	2646
2021 Q3	$12K	Sell	68 -2,047	-97%	-$329K	﹤0.01%	2118
2021 Q2	$341K	Buy	2,115 +4	+0.2%	+$642	0.01%	807
2021 Q1	$361K	Sell	2,111 -615	-23%	-$122K	0.01%	718
2020 Q4	$599K	Buy	+2,726	New	+$589K	0.02%	465

Other funds holding MRTX

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Aviva Holdings New Providence, Bahamas $20.5M AUM 117.01% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

O'Shaughnessy Asset Management's MRTX Position: Q4 2021 in Review

O'Shaughnessy Asset Management sold out of Mirati Therapeutics, Inc. Common Stock (MRTX) in Q4 2021, closing a stake of 68 shares — an estimated $12K sold.

O'Shaughnessy Asset Management first reported a position in MRTX in Q4 2020 and held it in 4 quarters. The position peaked at $599K in Q4 2020. 260 funds tracked by Wall St. Rank hold MRTX as of Q4 2021.

O'Shaughnessy Asset Management reported no remaining Mirati Therapeutics, Inc. Common Stock position as of Q4 2021 after selling out during the quarter.
O'Shaughnessy Asset Management sold 68 Mirati Therapeutics, Inc. Common Stock shares in Q4 2021, an estimated $12K.
O'Shaughnessy Asset Management first reported a position in Mirati Therapeutics, Inc. Common Stock in Q4 2020 and held it in 4 quarters.
O'Shaughnessy Asset Management's Mirati Therapeutics, Inc. Common Stock position peaked at $599K in Q4 2020.
260 funds tracked by Wall St. Rank held Mirati Therapeutics, Inc. Common Stock as of Q4 2021.

Based on O'Shaughnessy Asset Management's 13F filing for Q4 2021, filed 11 Feb 2022.